TB 500 5/10mg
£20.00
(NOT FOR HUMAN CONSUMPTION RESEARCH USE ONLY)
TB-500
is a synthetic peptide fragment of the naturally occurring protein thymosin beta-4 (Tβ4), studied for its potential in accelerating tissue repair, promoting new blood vessel formation, and reducing inflammation. It is not approved for human medical use by the FDA and is a substance banned by the World Anti-Doping Agency (WADA).
Function and Mechanism
TB-500 mimics the active site of the body's natural Tβ4 protein, which is highly concentrated at injury sites. Its primary mechanism of action centers on regulating actin, a protein crucial for cell structure and movement.
- Cell Migration: By managing actin dynamics, TB-500 facilitates the movement of repair cells (like endothelial cells and keratinocytes) to damaged areas, which is vital for wound healing.
- Angiogenesis: It stimulates the growth of new blood vessels, improving circulation and the delivery of oxygen and nutrients to injured tissues.
- Inflammation Control: TB-500 helps modulate the immune response, reducing pro-inflammatory factors and potentially aiding in chronic conditions like arthritis.
- Scar Reduction: Research in animal models suggests it may decrease the formation of scar tissue and fibrosis, leading to better quality tissue repair.
Status and Safety
TB-500 is primarily marketed as a "research chemical" and has a complex regulatory and safety profile.
- FDA Approval: TB-500 has not been approved for human use by the U.S. Food and Drug Administration (FDA) or similar regulatory bodies elsewhere. Human clinical trials on Tβ4 have focused on topical applications for specific conditions like dry eye syndrome, not systemic injury recovery.
- Legal Status: Its purchase and use fall into a medical gray zone. While it is not a scheduled controlled substance, it is not legally prescribed by medical doctors for general use.
- Doping: TB-500 is explicitly prohibited by the World Anti-Doping Agency (WADA) due to its performance-enhancing potential.